Examining Oversight Reports on the 340B Drug Pricing Program

Senate Committee on Health, Education, Labor, and Pensions Testimony on Examining Oversight Reports on the 340B Drug Pricing Program

Ann Maxwell, Assistant Inspector General, Office of Evaluations and Inspections, Office of Inspector General, U.S. Department of Health and Human Services